Literature DB >> 17333470

Can we learn more about the etiology of cardiovascular disease?

Lewis H Kuller1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17333470     DOI： 10.1007/s10654-007-9116-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  15 in total

1.  Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study.

Authors:  Ian F Godsland; Raymond Bruce; James A R Jeffs; Francisco Leyva; Christopher Walton; John C Stevenson
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

2.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study.

Authors:  Scott W Brouilette; Jasbir S Moore; Alex D McMahon; John R Thompson; Ian Ford; James Shepherd; Chris J Packard; Nilesh J Samani
Journal:  Lancet       Date:  2007-01-13       Impact factor: 79.321

3.  The Mediterranean diet story illustrates that "why" questions are as important as "how" questions in disease explanation.

Authors:  Johan P Mackenbach
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

4.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

Authors:  Jonathan C Cohen; Eric Boerwinkle; Thomas H Mosley; Helen H Hobbs
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

5.  Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.

Authors:  Lewis H Kuller; Gregory Grandits; Jerome D Cohen; James D Neaton; Ronald Prineas
Journal:  Atherosclerosis       Date:  2006-10-02       Impact factor: 5.162

Review 6.  The double jeopardy of HDL.

Authors:  Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Susan Hama; Greg Hough; Eugene Bachini; Victor R Grijalva; Alan C Wagner; Zory Shaposhnik; Alan M Fogelman
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

7.  The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

Authors:  Carlos Lorenzo; Ken Williams; Kelly J Hunt; Steven M Haffner
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

Review 8.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

Review 9.  INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary).

Authors:  J Stamler; P Elliott; B Dennis; A R Dyer; H Kesteloot; K Liu; H Ueshima; B F Zhou
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321
View more
  1 in total

1.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.